Glycogen synthase kinase-3 (GSK3): a potential therapeutic target to treat neuroinflammation?

Patrizia De Sarno, Robert C. Axtell, Chander Raman, Kevin A. Roth, Dario R. Alessi, Richard S. Jope

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{d27cccbc382142d68aebfd162ab4adc7,

title = "Glycogen synthase kinase-3 (GSK3): a potential therapeutic target to treat neuroinflammation?",

author = "{De Sarno}, Patrizia and Axtell, {Robert C.} and Chander Raman and Roth, {Kevin A.} and Alessi, {Dario R.} and Jope, {Richard S.}",

year = "2008",

month = oct,

day = "25",

language = "English",

volume = "203",

pages = "235--235",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Glycogen synthase kinase-3 (GSK3)

T2 - a potential therapeutic target to treat neuroinflammation?

AU - De Sarno, Patrizia

AU - Axtell, Robert C.

AU - Raman, Chander

AU - Roth, Kevin A.

AU - Alessi, Dario R.

AU - Jope, Richard S.

PY - 2008/10/25

Y1 - 2008/10/25

M3 - Article

SN - 0165-5728

VL - 203

SP - 235

EP - 235

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 2

M1 - 44

ER -